PRECIGEN, INC. Basic Shares Outstanding (Weighted Average)
PRECIGEN, INC. (PGEN) reported Basic Shares Outstanding (Weighted Average) of 356.89 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-04
- PRECIGEN, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 356.89M shares, a 20.40% increase year-over-year.
- PRECIGEN, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 354.29M shares, a 20.56% increase year-over-year.
- PRECIGEN, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 354.29M shares, a 20.86% increase year-over-year.
- PRECIGEN, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 307.17M shares, a 11.34% increase year-over-year.
- PRECIGEN, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 312.98M shares, a 16.90% increase from fiscal 2024.
- PRECIGEN, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 267.73M shares, a 9.48% increase from fiscal 2023.
- PRECIGEN, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 244.54M shares, a 22.05% increase from fiscal 2022.
- PRECIGEN, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 200.36M shares, a 1.32% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 356.89M shares 10-Q · filed 2026-08-04 | 355.60M shares 10-Q · filed 2026-08-04 | 355.16M shares derived: average of 3 quarters · filed 2026-08-04 | 343.16M shares derived: average of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | 354.29M shares 10-Q · filed 2026-05-13 | 354.29M shares derived: average of 2 quarters · filed 2026-05-13 | 338.58M shares derived: average of 3 quarters · filed 2026-05-13 | 328.05M shares derived: average of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | 354.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 330.73M shares derived: average of 2 quarters · filed 2026-03-25 | 319.30M shares derived: average of 3 quarters · filed 2026-08-04 | 312.98M shares 10-K · filed 2026-03-25 | |
| 2025-09-30 | 307.17M shares 10-Q · filed 2025-11-13 | 301.80M shares derived: average of 2 quarters · filed 2026-08-04 | 299.21M shares 10-Q · filed 2025-11-13 | 297.66M shares derived: average of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | 296.43M shares 10-Q · filed 2026-08-04 | 295.16M shares 10-Q · filed 2026-08-04 | 294.49M shares derived: average of 3 quarters · filed 2026-08-04 | 289.84M shares derived: average of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | 293.88M shares 10-Q · filed 2026-05-13 | 293.51M shares derived: average of 2 quarters · filed 2026-05-13 | 287.64M shares derived: average of 3 quarters · filed 2026-05-13 | 278.82M shares derived: average of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | 293.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 284.51M shares derived: average of 2 quarters · filed 2026-03-25 | 273.80M shares derived: average of 3 quarters · filed 2026-03-25 | 267.73M shares 10-K · filed 2026-03-25 | |
| 2024-09-30 | 275.88M shares 10-Q · filed 2025-11-13 | 264.12M shares derived: average of 2 quarters · filed 2025-11-13 | 259.25M shares 10-Q · filed 2025-11-13 | 256.60M shares derived: average of 4 quarters · filed 2026-03-25 | |
| 2024-06-30 | 252.37M shares 10-Q · filed 2025-08-12 | 250.80M shares 10-Q · filed 2025-08-12 | 250.17M shares derived: average of 3 quarters · filed 2026-03-25 | 249.76M shares derived: average of 4 quarters · filed 2026-03-25 | |
| 2024-03-31 | 249.22M shares 10-Q · filed 2025-05-14 | 249.07M shares derived: average of 2 quarters · filed 2026-03-25 | 248.89M shares derived: average of 3 quarters · filed 2026-03-25 | 248.67M shares derived: average of 4 quarters · filed 2026-03-25 | |
| 2023-12-31 | 248.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 248.72M shares derived: average of 2 quarters · filed 2026-03-25 | 248.48M shares derived: average of 3 quarters · filed 2026-03-25 | 244.54M shares 10-K · filed 2026-03-25 | |
| 2023-09-30 | 248.52M shares 10-Q · filed 2024-11-14 | 248.26M shares derived: average of 2 quarters · filed 2024-11-14 | 243.08M shares 10-Q · filed 2024-11-14 | 231.74M shares derived: average of 4 quarters · filed 2025-03-19 | |
| 2023-06-30 | 248.00M shares 10-Q · filed 2024-08-14 | 240.31M shares 10-Q · filed 2024-08-14 | 226.15M shares derived: average of 3 quarters · filed 2025-03-19 | 219.78M shares derived: average of 4 quarters · filed 2025-03-19 | |
| 2023-03-31 | 229.77M shares 10-Q · filed 2024-05-14 | 215.22M shares derived: average of 2 quarters · filed 2025-03-19 | 210.37M shares derived: average of 3 quarters · filed 2025-03-19 | 207.89M shares derived: average of 4 quarters · filed 2025-03-19 | |
| 2022-12-31 | 200.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | 200.67M shares derived: average of 2 quarters · filed 2025-03-19 | 200.60M shares derived: average of 3 quarters · filed 2025-03-19 | 200.36M shares 10-K · filed 2025-03-19 | |
| 2022-09-30 | 200.67M shares 10-Q · filed 2023-11-09 | 200.57M shares derived: average of 2 quarters · filed 2023-11-09 | 200.26M shares 10-Q · filed 2023-11-09 | 200.01M shares derived: average of 4 quarters · filed 2024-03-19 | |
| 2022-06-30 | 200.46M shares 10-Q · filed 2023-08-09 | 200.05M shares 10-Q · filed 2023-08-09 | 199.79M shares derived: average of 3 quarters · filed 2024-03-19 | 199.64M shares derived: average of 4 quarters · filed 2024-03-19 | |
| 2022-03-31 | 199.63M shares 10-Q · filed 2023-05-10 | 199.45M shares derived: average of 2 quarters · filed 2024-03-19 | 199.36M shares derived: average of 3 quarters · filed 2024-03-19 | 199.28M shares derived: average of 4 quarters · filed 2024-03-19 | |
| 2021-12-31 | 199.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | 199.23M shares derived: average of 2 quarters · filed 2024-03-19 | 199.16M shares derived: average of 3 quarters · filed 2024-03-19 | 197.76M shares 10-K · filed 2024-03-19 | |
| 2021-09-30 | 199.18M shares 10-Q · filed 2022-11-09 | 199.18M shares 10-Q · filed 2021-11-08 | 199.10M shares derived: average of 2 quarters · filed 2022-11-09 | 197.25M shares 10-Q · filed 2022-11-09 | 192.50M shares derived: average of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | 199.02M shares 10-Q · filed 2022-08-08 | 196.28M shares 10-Q · filed 2022-08-08 | 190.28M shares derived: average of 3 quarters · filed 2023-03-06 | 184.09M shares derived: average of 4 quarters · filed 2023-03-06 | |
| 2021-03-31 | 193.50M shares 10-Q · filed 2022-05-09 | 185.90M shares derived: average of 2 quarters · filed 2023-03-06 | 179.11M shares derived: average of 3 quarters · filed 2023-03-06 | 175.35M shares derived: average of 4 quarters · filed 2023-03-06 | |
| 2020-12-31 | 178.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 171.92M shares derived: average of 2 quarters · filed 2023-03-06 | 169.30M shares derived: average of 3 quarters · filed 2023-03-06 | 167.07M shares 10-K · filed 2023-03-06 | |
| 2020-09-30 | 165.53M shares 10-Q · filed 2021-11-08 | 164.80M shares derived: average of 2 quarters · filed 2021-11-08 | 163.32M shares 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | 164.07M shares 10-Q · filed 2021-08-09 | 162.20M shares 10-Q · filed 2021-08-09 | |||
| 2020-03-31 | 160.34M shares 10-Q · filed 2021-05-10 | ||||
| 2019-12-31 | 154.14M shares 10-K · filed 2022-03-01 | ||||
| 2016-03-31 | 116.86M shares 10-Q · filed 2016-05-10 | ||||
| 2015-03-31 | 106.10M shares 10-Q · filed 2016-05-10 | ||||
| 2014-09-30 | 99.89M shares 10-Q · filed 2014-11-13 | 98.71M shares 10-Q · filed 2014-11-13 | |||
| 2014-03-31 | 97.33M shares 10-Q · filed 2015-05-11 | ||||
| 2013-09-30 | 54.31M shares 10-Q · filed 2014-11-13 | 22.06M shares 10-Q · filed 2014-11-13 | |||
| 2013-03-31 | 5.66M shares 10-Q · filed 2014-05-09 | ||||
| 2012-09-30 | 5.58M shares 10-Q · filed 2013-11-07 | 5.51M shares 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |